InterCure Ltd. (INCR)

USD 1.42

(-1.05%)

Market Cap (In USD)

64.75 Million

Revenue (In USD)

355.55 Million

Net Income (In USD)

-61.95 Million

Avg. Volume

27.99 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.17-3.72
PE
-
EPS
-
Beta Value
0.033
ISIN
IL0011063760
CUSIP
M549GJ111
CIK
1857030
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Alexander Rabinovich
Employee Count
-
Website
https://www.intercure.co
Ipo Date
2019-01-28
Details
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.